September 20, 2010 – Patient enrollment has started in the EXCELLA BD Randomized Clinical Trial designed to evaluate Elixir Medical’s novolimus-eluting coronary stent with bioabsorbable coating, the Elixir DESyne BD. The first cases were enrolled by professor Joachim Schofer from the Universitäres Herz-und Gefä?zentrum in Hamburg, Germany, and Dr. Karl E.